Pacira BioSciences' Change in Account Payables fell 198587.13% to -$12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 22811.3%. This contributed to the annual value of $3.1 million for FY2024, which is 23668.12% up from last year.
Pacira BioSciences' Change in Account Payables amounted to -$12.0 million in Q3 2025, which was down 198587.13% from $6.9 million recorded in Q2 2025.
Pacira BioSciences' Change in Account Payables' 5-year high stood at $9.7 million during Q2 2024, with a 5-year trough of -$12.0 million in Q3 2025.
For the 5-year period, Pacira BioSciences' Change in Account Payables averaged around -$139947.4, with its median value being -$325000.0 (2024).
As far as peak fluctuations go, Pacira BioSciences' Change in Account Payables soared by 93293.98% in 2023, and later tumbled by 198587.13% in 2025.
Over the past 5 years, Pacira BioSciences' Change in Account Payables (Quarter) stood at -$9.4 million in 2021, then soared by 116.86% to $1.6 million in 2022, then tumbled by 167.38% to -$1.1 million in 2023, then soared by 69.68% to -$325000.0 in 2024, then plummeted by 3596.31% to -$12.0 million in 2025.
Its Change in Account Payables stands at -$12.0 million for Q3 2025, versus $6.9 million for Q2 2025 and $2.5 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value